Loading…
Back To Schedule
Wednesday, June 17 • 8:00am - 9:00am
#304.1 L: ICH 30th Anniversary: Achievements and Future Prospects

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-563-L04-P; CME 1.00; IACET 1.00; RN 1.00

This session will celebrate the key successes of the ICH Association in recognition of its 30th anniversary highlighting how the Association has evolved to respond to the increasingly global market and new advances in pharmaceutical development.

Learning Objectives

Identify key accomplishments of the ICH Association since it was founded in 1990; Discuss how ICH guidelines have contributed to more efficient drug development and increased patient access to pharmaceuticals worldwide; Explain how the reforms completed in 2015 have expanded the global reach of ICH and increased participation from regulators and industry around the world.

Chair

Amanda Marie Roache, MS

Speaker

MHLW/PMDA Perspective
Nobumasa Nakashima, PhD

European Commission Perspective
Lenita Lindström-Gommers, LLM

FDA Perspective
Theresa Mullin, PhD

IGBA Perspective
Nicholas Cappuccino, PhD

Panelist
Peter K. Honig, MD, MPH, FACP

Panelist
Celia Lourenco, PhD



Speakers
avatar for Amanda Roache

Amanda Roache

Senior Director, Science and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)
Amanda Roache, MPP, is a Senior Director in PhRMA’s Science and Regulatory Advocacy Department. She supports PhRMA’s ICH efforts and leads key science and regulatory activities related to ICH, international regulatory policy and advocacy in regional platforms such as APEC, and... Read More →
NC

Nicholas Cappuccino

Consultant, Compliance, Quality and Scientific Affairs, Dr. Reddy's Laboratories
Dr. Cappuccino is currently a Consultant for Dr. Reddy’s Laboratories Inc., located in Princeton, NJ, USA. Dr. Cappuccino currently serves as the Chair of the Science Committee for the International Generic and Biosimilar Medicines Association (IGBA) and represents IGBA on the ICH... Read More →
avatar for Celia Lourenco

Celia Lourenco

Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada
Celia Lourenco, PhD is the Director General of the Biologic and Radiopharmaceutical Drugs Directorate (BRDD) of the Health Products and Food Branch of Health Canada. She was previously the Senior Executive Director of the Therapeutic Products Directorate (TPD) and held other management... Read More →
avatar for Nobumasa Nakashima

Nobumasa Nakashima

Associate Executive Director for International Programs and Asia Training Centre, Pharmaceuticals and Medical Devices Agency (PMDA)
Dr. Nakashima holds the position of Associate Executive Director for International Programs and Asia Training Centre (ATC) at PMDA since January 2020. Before this position, he had joined MHLW in April 1992, where he worked as Director of Office of International Regulatory Affairs... Read More →
avatar for Lenita Lindström-Gommers

Lenita Lindström-Gommers

ICH Assembly Chair and Senior Expert, European Commission, European Commission
Lenita Lindström-Gommers is a Senior Expert in the Directorate General for Health and Food Safety (DG SANTE) in the European Commission where she is responsible for international relations in the field of pharmaceuticals. Her main work relates to ICH where she was closely involved... Read More →
PH

Peter Honig

Senior Vice President Global Regulatory Affairs and Group Head Development China, Pfizer Inc
Dr. Honig received his baccalaureate, medical and public health degrees from Columbia University in New York. He has postgraduate training and is board-certified in internal medicine, clinical pharmacology and has held senior leadership positions at US Food and Drug administration... Read More →
avatar for Theresa Mullin

Theresa Mullin

Associate Director for Strategic Programs, CDER, FDA
Theresa Mullin, Ph.D., serves as CDER’s Associate Director for Strategic Initiatives. She leads Patient-Focused Drug Development which includes implementation of the 21st Century Cures Act. She leads the CDER International program and heads the FDA delegation to ICH, IPRP and other... Read More →


Wednesday June 17, 2020 8:00am - 9:00am EDT
TBD Virtual Event Horsham, PA 19044
  09: Regulatory, Forum